
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4AB248AF2C22305AB24004ECC7472.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368223/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia">
<meta name="citation_author" content="Ashkan Shabannezhad">
<meta name="citation_author_institution" content="Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Nasrin Alizadghandforoush">
<meta name="citation_author_institution" content="Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Majid Safa">
<meta name="citation_author_institution" content="Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Shahrbano Rostami">
<meta name="citation_author_institution" content="Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Bahram Chahardouli">
<meta name="citation_author_institution" content="Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Ali Amini">
<meta name="citation_author_institution" content="Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30647">
<meta name="citation_doi" content="10.1038/s41598-025-13100-5">
<meta name="citation_pmid" content="40835851">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368223/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368223/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368223/pdf/41598_2025_Article_13100.pdf">
<meta name="description" content="Chronic myeloid leukemia (CML) is a clonal neoplasm originating from hematopoietic stem cells which is characterized by t(9;22)(q34;q11.2) fusion gene leading to forming an oncoprotein. miR-411 and SPRY4 may influence CML leukemogenesis by ...">
<meta name="og:title" content="Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Chronic myeloid leukemia (CML) is a clonal neoplasm originating from hematopoietic stem cells which is characterized by t(9;22)(q34;q11.2) fusion gene leading to forming an oncoprotein. miR-411 and SPRY4 may influence CML leukemogenesis by ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368223/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12368223">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-13100-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_13100.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368223%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12368223/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12368223/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368223/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 20;15:30647. doi: <a href="https://doi.org/10.1038/s41598-025-13100-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-13100-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shabannezhad%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ashkan Shabannezhad</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ashkan Shabannezhad</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shabannezhad%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ashkan Shabannezhad</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alizadghandforoush%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Nasrin Alizadghandforoush</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Nasrin Alizadghandforoush</span></h3>
<div class="p">
<sup>2</sup>Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alizadghandforoush%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nasrin Alizadghandforoush</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Safa%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Majid Safa</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Majid Safa</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Safa%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Majid Safa</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rostami%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shahrbano Rostami</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shahrbano Rostami</span></h3>
<div class="p">
<sup>2</sup>Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rostami%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shahrbano Rostami</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chahardouli%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Bahram Chahardouli</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Bahram Chahardouli</span></h3>
<div class="p">
<sup>2</sup>Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chahardouli%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bahram Chahardouli</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amini%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ali Amini</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ali Amini</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amini%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Amini</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Hematology and Blood Banking, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran </div>
<div id="Aff2">
<sup>2</sup>Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 27; Accepted 2025 Jul 22; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12368223  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40835851/" class="usa-link">40835851</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Chronic myeloid leukemia (CML) is a clonal neoplasm originating from hematopoietic stem cells which is characterized by t(9;22)(q34;q11.2) fusion gene leading to forming an oncoprotein. miR-411 and SPRY4 may influence CML leukemogenesis by regulating proliferation, differentiation, and various signaling pathways induced by the oncoprotein. In this cross-sectional study, a total of 90 blood samples were collected from individuals diagnosed with CML, covering three distinct clinical phases: 38 samples at the diagnosis, 38 samples one year after treatment with imatinib, and 14 samples during the blastic phase. The expression levels of miR-411 and SPRY4 genes were measured using real-time PCR. Statistical analysis was conducted using nonparametric tests. Using the Mann–Whitney U test, miR-411 expression was significantly upregulated post-treatment compared to the time of diagnosis (fold change: 15.6; <em>P</em> &lt; 0.0001), and downregulated in the blastic phase compared to the post-treatment phase (fold change: 1.84; <em>P</em> = 0.01). In contrast, SPRY4 expression was significantly downregulated post-treatment compared to the time of diagnosis (fold change: 4.5; <em>P</em> = 0.03), and upregulated in the blastic phase compared to the post-treatment phase (fold change: 7.8; <em>P</em> = 0.001). This study suggests that SPRY4 and miR-411 may exert phase-specific roles in CML progression probably with reverse pattern, although further studies are needed to clarify the role of these two genes in hematological malignancies such as CML.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Chronic myelogenous leukemia, miR-411, SPRY4, Hematologic malignancies, Hematologic neoplasm, Gene expression</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Myeloproliferative disease, miRNAs, Gene expression</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Chronic myeloid leukemia (CML) represents a clonal malignancy arising from hematopoietic stem cells, constituting roughly 15% of newly identified cases of leukemia in the adult population <sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. The prevalence of CML exhibits variability contingent upon factors such as age, sex, and geographic location <sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. The yearly prevalence of CML fluctuates between 0.4 per 100,000 individuals and 1.75 per 100,000 individuals across various nations <sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>. The occurrence of CML exhibits an upward trend with advancing age and is infrequently observed in pediatric populations under the age of 14 years <sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. In CML, a common cytogenetic abnormality is characterized by a reciprocal translocation involving the ABL1 gene located on the long arm of chromosome 9 and the BCR gene situated on the long arm of chromosome 22 (t(9;22)(q34;q11.2)), leading to the elongation of the long arm of chromosome 9 (+ 9q) and the reduction of the long arm on chromosome 22 (-22q). This altered and shorter chromosome 22 is called the Philadelphia chromosome (Ph) and is found in 95% of CML patients <sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>. This reciprocal chromosomal translocation results in the formation of an extraneous gene designated BCR::ABL1, which subsequently facilitates the synthesis of an additional BCR::ABL1 oncoprotein <sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>,<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. This oncoprotein, through the activation of numerous signaling cascades including RAS/RAF/MEK/ERK, JAK/STAT, Wnt/β-catenin, MYC, and JUN kinase, facilitates the enhancement of cellular proliferation and diminishes apoptosis, thereby contributing to the pathogenesis of leukemia <sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>–<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>. In 1998, sprouty RTK signaling antagonist 4 (SPRY4) was initially identified as an antagonist of the fibroblast growth factor receptor and epidermal growth factor signaling pathways in Drosophila <sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. In humans, four distinct subtypes (SPRY 1–4) have been characterized, which have been demonstrated to function as negative regulators of the RAS/MAPK/ERK signaling cascade <sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. In humans, SPRY4, possessing an approximate molecular mass of 32.541 kDa, is situated on the long arm of chromosome 5 (5q31.3) and encodes a protein comprised of 322 amino acids that belong to the cysteine-proline-rich protein family <sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. This protein features a cysteine-rich C-terminal domain (CRD), three SH3 binding motifs, and a PEST sequence, along with residues of tyrosine and serine <sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. Regarding the RAS/MAPK signaling cascade, the phosphorylated form of SPRY4 mediates the attenuation of RAS activation by obstructing the transition of RAS GDP to RAS GTP, while the non-phosphorylated variant of SPRY4 contributes to the inhibition of RAF1 activity <sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. On the other hand, one of the pathways activated by BCR-ABL1 is the RAS/MAPK kinase pathway, which is inhibited by SPRY4, so this is where these two pathways may interact together. Moreover, the ERK pathway serves as the principal route through which SPRY4 expression is upregulated <sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. Studies conducted on solid tumors reported that SPRY4 can act as both a tumor suppressor and an oncogene. Additionally, its role in hematological malignancies such as AML has been investigated, revealing that the expression of SPRY4 varies during the complete remission and at the diagnosis phase. SPRY4 plays a pivotal role in various cellular biological processes both under normal physiological conditions and in pathological circumstances <sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. Beyond its involvement in embryonic development and organogenesis <sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>,<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>, SPRY4 is implicated in apoptosis, cellular proliferation, responses to oxidative stress, inflammatory processes, ischemic injury, and tumorigenesis <sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. Ergo, as this gene’s expression was altered in hematological malignancies such as AML, we propose that it might exhibit increased or decreased expression in other hematological malignancies such as CML, which could be due to the aforementioned signaling pathways (such as ERK, etc.).</p>
<p id="Par3">In the entirety of the human genome, genes that code for proteins constitute less than 2%, whereas non-coding RNAs represent over 98% <sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>,<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>. MicroRNA (miRNA) is classified as a single-stranded non-coding RNA, typically ranging from 18 to 25 nucleotides in length, which is ubiquitously found in eukaryotic organisms, with its primary role being the regulation of mRNA expression, thereby influencing the initiation and progression of oncogenesis <sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>,<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>. Although miRNAs encompass only 1–3% of the total gene repertoire, they exert regulatory control over more than 30% of gene expression in the human population <sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. The miR-411 gene is situated on chromosome 14, and its precursor miRNA can undergo processing by the Dicer enzyme to yield two distinct mature miRNAs, namely miR-411-3p and miR-411-5p. Notably, miR-411-3p exhibits low levels of expression and is prone to degradation <sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>. Thus, miR-411 demonstrates aberrant expression patterns across various cancer types. The dysregulation of miR-411 can significantly impact numerous cancer-related cellular processes, including proliferation, invasion, migration, apoptosis, and colony formation <sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. By targeting a variety of genes, miR-411 contributes to the activation of several significant signaling cascades, including MAPK, P53, Ras, NF-kB, and Wnt/β-catenin pathways. On the other hand, BCR-ABL has the potential to influence GRB2, a component of the Ras/MAPK signaling cascade, as well as the Wnt/β-catenin and PI3K/AKT/mTOR pathways. Consequently, given that miR-411 possesses the capability to modulate the aforementioned pathways that are also impacted by BCR-ABL, it may interact with this gene fusion in an indirect manner <sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>. The expression profile of miR-411 varies across different malignancies; in certain cancers, its expression diminishes, whereas, in others, it is augmented, thereby enabling it to function as both an oncogene and a tumor suppressor <sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. Overall, only two studies have examined the association between SPRY4 and miR-411 genes in solid tumors such as rhabdomyosarcoma and lung cancer, but not in hematological malignancies <sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>. Therefore, they formed the basis of our study design.</p>
<p id="Par4">Tyrosine kinase inhibitors (TKIs) represent a class of pharmacological agents employed in the management of various malignancies, particularly those characterized by mutations in the epidermal growth factor receptor (EGFR) or the KIT gene. Nonetheless, the emergence of resistance to these therapeutic agents poses a significant obstacle within clinical treatment paradigms. A few studies reported that the SPRY4 and miR-411 genes may be contributors to the mechanisms underlying this resistance. A study revealed that SPRY4 gene has the capacity to increase sensitivity to TKIs by attenuating the activity of EGFR and MAPK signaling pathways; however, its downregulation in the context of TKIs such as osimertinib may facilitate resistance development. On the other hand, by modulating SPRY4 expression, miR-411 can indirectly contribute to resistance, as the silencing of SPRY4 promotes the activation of pathways that are implicated in resistance mechanisms. Nevertheless, a modified variant of miR-411, specifically the A-to-I edited form of miR-411-5p, has the potential to enhance the response to TKIs, a hypothesis that warrants further empirical exploration. Therefore, when examining the effect of these genes in CML, it is better to also consider the possible effect of these genes on TKI resistance <sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>,<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>.</p>
<p id="Par5">Considering the numerous investigations conducted on SPRY4 and miR-411 genes in solid tumors and the lack of studies in blood malignancies such as CML, the effect of these two genes on at least one of the important signaling pathways in CML, and also the different behavior of this gene in different cancers (being an oncogene or tumor suppressor), this study aimed to assess the expressions of these two genes in patients with CML.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Population study</h3>
<p id="Par6">In this cross-sectional study, which was undertaken from May 23, 2023, to May 23, 2024, a total of 90 blood specimens were procured from patients diagnosed with CML within Shariati Hospital, Tehran, Iran. This study was conducted under the regulations of the Medical Ethics Committee of Iran University of Medical Sciences (approval No. IR.IUMS.REC.1402.196), and all methods were performed in accordance with relevant guidelines and regulations. The samples were collected from patients across three distinct phases: at the point of diagnosis (comprising 38 patients, including 22 males and 16 females); one year after treatment with imatinib (consisting of 38 patients, incorporating 22 males and 16 females); and during the blastic phase (involving 14 patients, with 11 males and 3 females). The "at the time of diagnosis" group served as the reference group, against which the patients in the subsequent two groups were evaluated. The inclusion criteria encompassed patients who received a diagnosis of CML confirmed by an oncologist’s assessment and supported by molecular or cytogenetic testing. It should be noted that all CML patients who entered the study had the P210 isoform, and all patients in the treatment group received the same tyrosine kinase inhibitor (TKI) i.e., imatinib. The exclusion criteria comprised instances of patient non-cooperation regarding sampling, the incompleteness of laboratory data pertaining to the patients, and the presence of other underlying medical conditions aside from CML. Laboratory parameters, including hemoglobin levels, platelet and white blood cell counts, molecular evaluation of the BCR::ABL1 fusion, and determination of the BCR::ABL1:ABL1% ratio, in order to determine the Minimal Residual Disease (MRD) after treatment, were assessed. Detailed information on the patients’ data was presented in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Demographic and laboratory characteristics of patients among all three phases of CML.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Variable</th>
<th align="left" colspan="1" rowspan="1">At the diagnosis phase</th>
<th align="left" colspan="1" rowspan="1">One-year post treatment phase</th>
<th align="left" colspan="1" rowspan="1">Blastic phase</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age*</td>
<td align="left" colspan="1" rowspan="1">47.4 ± 13</td>
<td align="left" colspan="1" rowspan="1">48.4 ± 13</td>
<td align="left" colspan="1" rowspan="1">42.5 ± 14.3</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Gender*</td>
<td align="left" colspan="1" rowspan="1">M: 22</td>
<td align="left" colspan="1" rowspan="1">M: 22</td>
<td align="left" colspan="1" rowspan="1">M: 11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">F: 16</td>
<td align="left" colspan="1" rowspan="1">F: 16</td>
<td align="left" colspan="1" rowspan="1">F: 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">WBC*</td>
<td align="left" colspan="1" rowspan="1">119,921 ± 83,066</td>
<td align="left" colspan="1" rowspan="1">7725 (5632–9635)<sup>†</sup>
</td>
<td align="left" colspan="1" rowspan="1">17,500 (10,350–95,750)<sup>†</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hb*</td>
<td align="left" colspan="1" rowspan="1">11.4 ± 2.5</td>
<td align="left" colspan="1" rowspan="1">13.9 ± 2.1</td>
<td align="left" colspan="1" rowspan="1">8.9 ± 1.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PLT*</td>
<td align="left" colspan="1" rowspan="1">320,000 (243,000–507,500)<sup>†</sup>
</td>
<td align="left" colspan="1" rowspan="1">213,868 ± 91,987</td>
<td align="left" colspan="1" rowspan="1">64,335 ± 46,857</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Blastic Type**</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">AML: 7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">ALL: 7</td>
</tr>
<tr>
<td align="left" rowspan="7" colspan="1">MRD Type**</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">CHR: 4</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">CCyR: 10</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">MR3: 14</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">MR4: 2</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">MR4.5: 1</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">MR5: 1</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Failure: 6</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p8">
<p>*Parameters were reported as Mean ± SD, **parameters were reported as number, <sup>†</sup>Parameters were reported as Median with IQR.</p>
<p>WBC: White Blood Cell, Hb: Hemoglobin, PLT: Platelet, MRD: Minimal Residual Disease, CHR: Complete Hematologic Response, CCyR: Complete Cytogenic Response, MR: Molecular response, MR3 = MMR: Major Molecular Response, M: Male, F: Female.</p>
</div></div></section></section><section id="Sec4"><h3 class="pmc_sec_title">RNA extraction, and cDNA synthesis</h3>
<p id="Par7">Due to the presence of the BCR::ABL1 fusion in all leukocytes, a buffy coat was employed for the isolation of RNA. Whole blood samples obtained from patients diagnosed with CML were subjected to centrifugation at 800 g for 10 min. The Buffy coat, which constitutes the intermediary layer between the plasma and erythrocytes, was subsequently isolated. Trizol reagent was added to the Buffy coat and allowed to incubate for 15 min. Ultimately, RNA was extracted utilizing chloroform, isopropanol, and ethanol (75%) solutions. The quantity of the isolated RNA was determined by assessing the A260/A280 nm and A260/A230 nm ratios via a NanoDrop UV–visible spectrophotometer (Thermo Scientific, USA). Additionally, in order to assess the quality of the extracted RNA to prevent erroneous results in qPCR, such as when the RNAs undergo degradation, 1% agarose gel electrophoresis followed by conventional PCR was conducted. After RNA extraction, DNase treatment (Thermofisher, Germany) was administered using DNase I, buffer, and EDTA solutions to mitigate the interfering effects of DNA. Thereafter, 1 µg of the treated RNA was reverse transcribed into complementary DNA (cDNA) following the protocol outlined in the cDNA synthesis kit (Yekta Tajhiz Azma, Iran). For cDNA synthesis of SPRY4 and β-actin genes, 0.5 µL Oligo dT primer, 0.5 µL Random hexamer primer, 5.75 µL from the DNase treatment step, 0.5 µL dNTP, 2 µL Buffer, 0.25 µL RNase inhibitor, and 0.5 µL RT enzyme (total volume = 10 µL) were mixed together, and the process was carried out according to the temperature profile: (1) Primer Annealing: 15 min at 37°C; (2) Amplification: 60 min at 42°C; (3) Inactivation: 5 min at 70°C; (4) Final Step: 10 min at 4°C for temporary storage and to maintain product stability. However, cDNA synthesis of miR-411 and U6 was carried out according to the temperature profile: (1) 30 min at 16°C; (2) 30 min at 42°C; (3) 5 min at 70°C. It is imperative to note that for the cDNA synthesis of miR-411 and U6 at this juncture, the stem-loop for each respective gene was incorporated (the sequences of the stem-loop primers are delineated in Table <a href="#Tab2" class="usa-link">2</a>), whereas oligo dT and Random Hexamer were utilized for the SPRY4 and actin genes.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Sequences of stem-loop primers used for miR-411 and U6 cDNA synthesis.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Gene</th>
<th align="left" colspan="1" rowspan="1">Primer Sequences (5’ to 3’)</th>
<th align="left" colspan="1" rowspan="1">Length (Base-pair)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">miR-411</td>
<td align="left" colspan="1" rowspan="1">GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCGTAC</td>
<td align="left" colspan="1" rowspan="1">49</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">U6</td>
<td align="left" colspan="1" rowspan="1">GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTATGGA</td>
<td align="left" colspan="1" rowspan="1">50</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec5"><h3 class="pmc_sec_title">Real-time PCR</h3>
<p id="Par8">Semi-quantitative real-time polymerase chain reaction (RT-PCR) was conducted utilizing a Roche light cycler (Germany). For the real-time amplification process, two distinct series of reactions were undertaken: 1. for SPRY4 and Actin genes, and 2. for miR-411 and U6 genes. In accordance with the protocols provided by the manufacturer, a final reaction volume of 15 μl was employed for each assay, which encompassed 7.5 µl of Master-Mix 2 × SYBR green without ROX (Ampliqon, Denmark), 1.5 µl (for miR-411 and U6) and 1 µl (for SPRY4 and Actin) of both forward and reverse primers, alongside 5 µl (for miR-411 and U6) and 5.5 µl (for SPRY4 and Actin) of distilled water (DW). The RT-PCR reaction incorporated a preincubation phase at 95°C for 15 min, followed by a two-step amplification process (40 cycles) comprised of 95°C for 10 s and 60°C for 60 s (annealing/extension). Each specimen was subjected to analysis in duplicate, and melting curve analysis was employed to ascertain the specificity of the PCR products. Efficiency testing was performed for all four primers, and since the R<sup>2</sup> index was above 0.99, the Livak method was utilized to compute the fold change expression of the SPRY4 gene relative to Actin (the housekeeping gene) and miR-411 in relation to U6 (the housekeeping gene). The primer sequences utilized in the real-time PCR reaction are presented in Table <a href="#Tab3" class="usa-link">3</a>.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Sequences of primers used for RQ-PCR.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Gene</th>
<th align="left" colspan="1" rowspan="1">Primer sequences (5’ to 3’)</th>
<th align="left" colspan="1" rowspan="1">Product length (Base-pair)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="2" colspan="1">miR-411</td>
<td align="left" colspan="1" rowspan="1">Forward: CAGCCTAGTAGACCGTATAGCG</td>
<td align="left" rowspan="2" colspan="1">90</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Universal reverse: CAGTGCAGGGTCCGAGGTA</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1">U6</td>
<td align="left" colspan="1" rowspan="1">Forward: CGCAAGGATGACACGCAAATTC</td>
<td align="left" rowspan="2" colspan="1">91</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Universal reverse: CAGTGCAGGGTCCGAGGTA</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1">SPRY4</td>
<td align="left" colspan="1" rowspan="1">Forward: TGCTGCTCACTGTCATAGCC</td>
<td align="left" rowspan="2" colspan="1">109</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Reverse: CTGCTGGGGCTTCCTAACAC</td></tr>
<tr>
<td align="left" rowspan="2" colspan="1">Actin</td>
<td align="left" colspan="1" rowspan="1">Forward: GGAAATCGTGCGTGACATTAAG</td>
<td align="left" rowspan="2" colspan="1">181</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Reverse: GAAGGAAGGCTGGAAGAGTG</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec6"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par9">The statistical analysis of data was conducted utilizing SPSS version 27.0 and Prism version 10.4.0 software. The Kolmogorov–Smirnov or the Shapiro–Wilk test was employed to assess the normality of the data distribution. The independent samples t-test and the Mann–Whitney U test (if the data distribution was not normal) were applied to compare the means between the two groups. Correlation analyses were performed using either Pearson’s or Spearman’s correlation coefficient, contingent upon the results of the normality assessment, to examine the relationship between two quantitative variables. A statistically significant difference was defined as <em>P</em> &lt; 0.05.</p></section></section><section id="Sec7"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec8"><h3 class="pmc_sec_title">Descriptive data</h3>
<p id="Par10">A complete blood count (CBC) was conducted for each patient during every distinct phase of the disease. In the chronic, post-treatment, and blastic phases, the average white blood cell count was 119,921 ± 83,066, 9,081 ± 6,992, and 81,237 ± 62,827, respectively; the average hemoglobin levels were recorded as 11.4 ± 2.5, 13.9 ± 2.1, and 8.9 ± 1.6, respectively; and the average platelet count was 650,605 ± 124,668, 213,868 ± 91,987, and 64,335 ± 46,857, respectively. Given that the patients in this investigation were paired samples "at the time of diagnosis" and "one year after treatment," the mean age of patients at diagnosis was determined to be 47.4 ± 13, while the mean age one year after treatment was 48.4 ± 13. Nevertheless, the mean age of patients within the blastic group was assessed at 42.5 ± 14.3. All numerical values stated above were reported as mean ± SD (standard deviation). Some of the data in CBC were not normally distributed and had skewness, as reported in Table <a href="#Tab1" class="usa-link">1</a>. The minimal residual disease (MRD) levels of patients were evaluated one year after treatment with imatinib. MRD was classified into 6 subgroups: (1) complete hematological remission (CHR): BCR-ABL at a level of &lt; 10%; (2) complete cytogenetic response (CCyR): BCR-ABL at a level of &lt; 1%; (3) major molecular response (MMR-MR3): BCR-ABL at a level of &lt; 0.1%; (4) MR4: BCR-ABL at a level of &lt; 0.01%; (5) MR4.5: BCR-ABL at a level of &lt; 0.0032%; (6) MR5: BCR-ABL at a level of &lt; 0.001%. Based on the above classification, 4 patients had CHR (10.5%), 10 patients achieved CCyR (26.3%), 14 patients reached MR3 (36.8%), 2 patients accomplished MR4 (5.3%), 1 patient reached MR4.5 (2.6%), and 1 patient achieved MR5 (2.6%), whereas 6 patients exhibited no response to the treatment (15.8%). Among the 14 patients who progressed into the blastic phase, 7 patients (50%) developed acute myeloid leukemia (AML) and 7 patients (50%) developed acute lymphoblastic leukemia (ALL).</p></section><section id="Sec9"><h3 class="pmc_sec_title">Expression level of miR-411 in patients with CML</h3>
<p id="Par11">As depicted in Fig. <a href="#Fig1" class="usa-link">1</a>, miR-411 expression demonstrated a significant upregulation in patients one year after treatment when contrasted with individuals at the time of diagnosis (fold change: 15.6; <em>P</em> &lt; 0.0001). The expression level of the miR-411 gene exhibited a significant upregulation during the blastic phase in comparison to the "at the time of diagnosis" phase (fold change: 8.5; <em>P</em> = 0.01). Moreover, the mentioned gene expression was significantly downregulated in patients experiencing the blastic phase relative to those who received treatment (fold change: 1.84; <em>P</em> = 0.01).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94b/12368223/8d404a298749/41598_2025_13100_Fig1_HTML.jpg" loading="lazy" id="d33e659" height="476" width="570" alt="Fig. 1"></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Expression levels of the miR-411 gene in three phases in patients with CML. The results are expressed as the mean ± SEM. *<em>p</em> ≤ 0.05, ***<em>p</em> ≤ 0.0001.</p></figcaption></figure></section><section id="Sec10"><h3 class="pmc_sec_title">SPRY4 expression in CML patients</h3>
<p id="Par12">Regarding the expression of SPRY4, it was observed that SPRY4 expression was significantly downregulated in patients one year after treatment, in contrast to individuals at the time of diagnosis (fold change: 4.5; <em>P</em> = 0.03). The expression level of the SPRY4 gene was significantly upregulated during the blastic phase when compared to the "at the time of diagnosis" phase (fold change: 1.7; <em>P</em> = 0.03) (Fig. <a href="#Fig2" class="usa-link">2</a>). In addition, the expression of the mentioned gene was significantly upregulated in patients during the blastic phase in comparison to patients who underwent treatment (fold change: 7.8; <em>P</em> = 0.001).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c94b/12368223/89f8c6754471/41598_2025_13100_Fig2_HTML.jpg" loading="lazy" id="d33e689" height="524" width="559" alt="Fig. 2"></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>SPRY4 gene expression levels in three phases in patients with CML. The results are presented as the mean ± SEM. *<em>p</em> ≤ 0.05, ***<em>p</em> ≤ 0.001.</p></figcaption></figure></section><section id="Sec11"><h3 class="pmc_sec_title">Correlation analyses between miR-411 and SPRY4 gene expression and laboratory variables</h3>
<p id="Par13">As shown in Table <a href="#Tab4" class="usa-link">4</a>, a significant association was found between the mean expression level of the SPRY4 gene during the treatment phase and the specific type of blastic phase (transformation into AML or ALL) (<em>P</em> = 0.02). However, concerning miR-411, a significant correlation was noted between the mean expression of this gene at the time of diagnosis and the type of blastic phase (transformation into AML or ALL) (<em>P</em> = 0.03). No significant correlation was identified between the mean expression levels of the SPRY4 and miR-411 genes in the post-treatment phase and the type of MRD following treatment (<em>P</em> &gt; 0.05).</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Correlation analysis between miR-411 and SPRY4 gene expression and laboratory findings.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">miR-411 (at the time of diagnosis)</th>
<th align="left" colspan="1" rowspan="1">miR-411 (one-year post treatment)</th>
<th align="left" colspan="1" rowspan="1">miR-411 (Blastic phase)</th>
<th align="left" colspan="1" rowspan="1">SPRY4 (at the time of diagnosis)</th>
<th align="left" colspan="1" rowspan="1">SPRY4 (one-year post treatment)</th>
<th align="left" colspan="1" rowspan="1">SPRY4 (Blastic phase)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="2" colspan="1">WBC (at the time of diagnosis)</td>
<td align="left" colspan="1" rowspan="1">r: − 0.27</td>
<td align="left" colspan="1" rowspan="1">r: − 0.17</td>
<td align="left" colspan="1" rowspan="1">r: 0.24</td>
<td align="left" colspan="1" rowspan="1">r: 0.24</td>
<td align="left" colspan="1" rowspan="1">r: 0.17</td>
<td align="left" colspan="1" rowspan="1">r: − 0.24</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.1</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.32</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.42</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.42</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.93</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.44</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">WBC (one-year post treatment)</td>
<td align="left" colspan="1" rowspan="1">r: − 0.2</td>
<td align="left" colspan="1" rowspan="1">r: 0.17</td>
<td align="left" colspan="1" rowspan="1">r: 0.09</td>
<td align="left" colspan="1" rowspan="1">r: − 0.18</td>
<td align="left" colspan="1" rowspan="1">r: 0.58*</td>
<td align="left" colspan="1" rowspan="1">r: − 0.32</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.27</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.32</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.74</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.3</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.001</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.29</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">WBC (Blastic phase)</td>
<td align="left" colspan="1" rowspan="1">r: 0.06</td>
<td align="left" colspan="1" rowspan="1">r: − 0.01</td>
<td align="left" colspan="1" rowspan="1">r: − 0.003</td>
<td align="left" colspan="1" rowspan="1">r: 0.14</td>
<td align="left" colspan="1" rowspan="1">r: 0.1</td>
<td align="left" colspan="1" rowspan="1">r: − 0.16</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.8</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.97</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.99</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.67</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.77</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.61</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Hb (at the time of diagnosis)</td>
<td align="left" colspan="1" rowspan="1">r: − 0.03</td>
<td align="left" colspan="1" rowspan="1">r: − 0.3</td>
<td align="left" colspan="1" rowspan="1">r: − 0.07</td>
<td align="left" colspan="1" rowspan="1">r: − 0.17</td>
<td align="left" colspan="1" rowspan="1">r: 0.03</td>
<td align="left" colspan="1" rowspan="1">r: 0.06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.84</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.57</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.8</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.34</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.85</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.84</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Hb (one-year post treatment)</td>
<td align="left" colspan="1" rowspan="1">r: 0.08</td>
<td align="left" colspan="1" rowspan="1">r: 0.39*</td>
<td align="left" colspan="1" rowspan="1">r: 0.06</td>
<td align="left" colspan="1" rowspan="1">r: 0. 13</td>
<td align="left" colspan="1" rowspan="1">r: 0.16</td>
<td align="left" colspan="1" rowspan="1">r: 0.64</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.64</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.02</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.8</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.43</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.39</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.68</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Hb (Blastic phase)</td>
<td align="left" colspan="1" rowspan="1">r: − 0.45</td>
<td align="left" colspan="1" rowspan="1">r: − 0.5</td>
<td align="left" colspan="1" rowspan="1">r: 0.1</td>
<td align="left" colspan="1" rowspan="1">r: − 0.24</td>
<td align="left" colspan="1" rowspan="1">r: 0.62</td>
<td align="left" colspan="1" rowspan="1">r: − 0.56</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.1</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.07</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.6</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.46</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.06</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.56</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">PLT (at the of time diagnosis)</td>
<td align="left" colspan="1" rowspan="1">r: − 0.4*</td>
<td align="left" colspan="1" rowspan="1">r: 0.26</td>
<td align="left" colspan="1" rowspan="1">r: 0.2</td>
<td align="left" colspan="1" rowspan="1">r: − 0.03</td>
<td align="left" colspan="1" rowspan="1">r: − 0.06</td>
<td align="left" colspan="1" rowspan="1">r: 0.21</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.02</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.13</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.48</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.83</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.74</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.51</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">PLT (one-year post treatment)</td>
<td align="left" colspan="1" rowspan="1">r: − 0.05</td>
<td align="left" colspan="1" rowspan="1">r: 0.25</td>
<td align="left" colspan="1" rowspan="1">r: 0.28</td>
<td align="left" colspan="1" rowspan="1">r: − 0.15</td>
<td align="left" colspan="1" rowspan="1">r: 0.37</td>
<td align="left" colspan="1" rowspan="1">r: − 0.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.7</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.14</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.33</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.37</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.51</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.72</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">PLT (Blastic phase)</td>
<td align="left" colspan="1" rowspan="1">r: 0.3</td>
<td align="left" colspan="1" rowspan="1">r: 0.16</td>
<td align="left" colspan="1" rowspan="1">r: 0.28</td>
<td align="left" colspan="1" rowspan="1">r: 0.1</td>
<td align="left" colspan="1" rowspan="1">r: 0.07</td>
<td align="left" colspan="1" rowspan="1">r: − 0.56</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.26</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.59</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.34</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.75</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.83</td>
<td align="left" colspan="1" rowspan="1">
<em>P</em> value: 0.54</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p22"><p>*Spearman’s correlation coefficient.</p></div></div></section><p id="Par14">There existed a weak negative correlation between the average expression levels of the SPRY4 and miR-411 genes at the time of diagnosis phase; however, this correlation did not reach statistical significance (r = − 0.1, <em>P</em> &gt; 0.05). A statistically significant correlation was observed between the average expression of the SPRY4 gene during the post-treatment phase and the mean WBC count after treatment (r = 0.58, <em>P</em> = 0.001). Conversely, no statistically significant correlation was identified between the average miR-411 expression across all three phases and the mean WBC count (<em>P</em> &gt; 0.05). As well, a significant correlation was noted between the average expression of the miR-411 gene during the treatment phase and the mean hemoglobin (Hb) value during the post-treatment phase (r = 0.39, <em>p</em> = 0.02). Nonetheless, there was an absence of a statistically significant correlation between the average expression of the SPRY4 gene across all three phases and the mean Hb count (<em>P</em> &gt; 0.05). Into the bargain, a significant correlation was found between miR-411 expression at the time of diagnosis and the mean platelet count at the same time point (r = − 0.4, <em>p</em> = 0.02). Nevertheless, there was no significant correlation between the average expression of SPRY4 across all three phases and the mean platelet count (<em>P</em> &gt; 0.05). Moreover, a correlation analysis was conducted between the average age in all phases and the level of gene expression in each phase, and no significant correlation was observed (<em>P</em> &gt; 0.05).</p></section></section><section id="Sec12"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par15">miR-411 exhibits differential expression profiles across various malignancies, with certain cancers demonstrating diminished expression levels while others reveal elevated expression, thereby functioning as both an oncogene and a tumor suppressor <sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. Based on our research, the expression of the miR-411 gene was significantly upregulated in patients who underwent treatment for one year, in comparison to individuals at the time of diagnosis (fold change: 15.6). As the disease progressed to a more aggressive state and transitioned into the blastic phase, the expression of the mentioned gene was downregulated compared to patients who underwent treatment (fold change: 1.84). Hence, this molecule probably fulfills a specific role in CML. The BCR::ABL1 protein possesses the capability to activate critical signaling cascades, among which is the PI3K-AKT-mTOR pathway. The activation of this pathway results, on one hand, in enhanced cellular proliferation, migration, and invasion, while simultaneously, on the other hand, it diminishes the process of apoptosis <sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>. Another significant signaling pathway activated by the BCR::ABL1 protein is the Ras/MAPK pathway <sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>. GRB2 is an integral component of the Ras/MAPK signaling cascade, and by activating SOS, it precipitates the activation of Ras, Raf-1, MEK1/2, and ERK1/2, which ultimately promotes cellular growth and differentiation <sup><a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>. Zhang et al. reported that miR-411 inhibits GRB2 expression in breast cancer. Ergo, by diminishing miR-411 expression, its inhibitory impact on this signaling pathway is negated, resulting in the unrestrained activation of this pathway. Another significant finding derived from this study indicated that patients exhibiting elevated expression levels of miR-411 and, consequently, reduced levels of GRB2, experienced a prolonged overall survival in comparison to their counterparts <sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>. Besides, the BCR::ABL1 protein can also instigate the activation of the Wnt/β-catenin signaling pathway. The activation of this signaling pathway results in enhanced cellular proliferation, migratory capacity, invasive potential, and diminished apoptotic activity. Liu et al. demonstrated that elevated levels of miR-411 contribute to the suppression of β-catenin activity in colorectal carcinoma <sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>. Accumulating studies collectively underscore the tumor-suppressive properties of miR-411, aligning with the findings of our research. In our study, the tumor suppressive role of miR-411 could be due to the recruitment of one of the mediators involved in the previously mentioned signaling pathways (GRB2, β-catenin, etc.). One of the limitations of our investigation was the absence of assays such as luciferase assays and Western blots, which would have corroborated the involvement of these two genes in CML. Consequently, attributing the results of our research to variables such as GRB2, β-catenin, or Akt remains a theoretical proposition, and these findings may be contingent upon elements beyond these factors. Hence, subsequent research endeavors may elucidate the precise function of these two genes in CML through conducting the aforementioned assays. In contrast, several studies demonstrated an oncogenic role of miR-411. In Xia et al.'s research, the expression levels of miR-411 in hepatocellular carcinoma (HCC) tumor tissues and some HCC cell lines exhibited a significant increase compared to normal liver cell lines and adjacent tissue <sup><a href="#CR45" class="usa-link" aria-describedby="CR45">45</a></sup>. In another study, the expression of miR-411 in malignant tissues from patients with non-small cell lung cancer (NSCLC) and cell lines was notably increased relative to normal bronchial epithelial cell lines <sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. The other inquiry reported that the expression level of miR-411 was higher in either the tissues or serum, as well as osteosarcoma cell lines, compared to those observed in healthy tissue, serum, and cell lines <sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>. The discrepancies in miR-411 expression across the three previously mentioned malignancies may stem from some factors: 1. The limited sample sizes in each investigation, with the majority comprising approximately 30 pairs; 2. The heterogeneous clinicopathological characteristics of cancer patients, which could contribute to variable expression levels of miR-411; 3. The utilization of distinct cell lines across different studies may result in a lack of comparability among findings. As a result, the observed contradictory results underscore the necessity for more expansive research endeavors to elucidate the mechanistic role of miR-411 across various cancers, particularly in hematological malignancies, given the insufficient number of studies addressing these specific malignancies, such as CML.</p>
<p id="Par16">SPRY4 is crucial in the modulation of the receptor tyrosine kinase (RTK) signaling pathway and governs essential facets of organogenesis, developmental processes, and the onset of malignant tumors <sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. The significance of SPRY proteins across various cellular lineages is influenced by diverse tumor milieus. Therefore, akin to miR-411, which exhibits differential expression across various malignancies, SPRY4 similarly possesses the characteristic of variable expression; its expression is diminished in certain cancers, while in others it is augmented. Although SPRY4 functions primarily as a tumor suppressor in the majority of cells, it may also exhibit oncogenic properties in a limited number of malignancies <sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. The function of SPRY4 has predominantly been explored in solid tumors. In research on perihilar cholangiocarcinoma (PHCC), the expression of SPRY4 in PHCC tumor tissues was markedly diminished compared to that in neighboring tumor-associated tissues. An additional finding from this study indicated that SPRY4 inhibited cell proliferation and migration by suppressing ERK phosphorylation. Hence, a tumor-suppressive function of SPRY4 was revealed in PHCC <sup><a href="#CR49" class="usa-link" aria-describedby="CR49">49</a></sup>. In another study implemented by Xiaoling et al. on human colorectal cancer (CRC) cell lines, SPRY4 expression was downregulated in CRC tumor tissues and significantly associated with tumor invasion and metastasis, thereby implying that SPRY4 may serve as a tumor suppressor during the progression of human CRC <sup><a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup>. In addition to pursuing the role of SPRY4 in solid tumors, SPRY4 was also engaged in hematological malignancies such as AML. Olivia et al. undertook an exploration on Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), measuring the copy number of the SPRY4 gene in samples collected at two distinct times in MDS: at the point of diagnosis (MDS-Dg) and during complete cytogenetic remission subsequent to azacytidine treatment (MDS-CR). Moreover, in AML, assessments were made at three specific time intervals: at the moment of diagnosis (AML-Dg), during complete cytogenetic remission (AML-CR), and upon relapse. It has been documented that during the complete remission phases in patients with AML and MDS, the expression levels of SPRY4 exhibited an increase when compared to the initial diagnostic stage; conversely, a decline in expression was noted at the time of relapse in AML patients <sup><a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>. In contrast to previous findings, our research indicated that SPRY4 gene expression was downregulated in patients who underwent treatment for one year, in comparison to individuals at the time of diagnosis (fold change: 4.5). As the disease progressed to the blastic phase, the expression of this gene was observed to be upregulated compared to patients who underwent treatment (fold change: 7.8). Ergo, our study elucidated that this gene may serve a potential role in CML. Das et al. reported that the levels of SPRY4, both mRNA and protein, were significantly elevated in human testicular germ cell tumor (TGCT) cell lines (the 833K and NT2-D1 cell lines), compared to those observed in normal adult testicular tissue. They articulated that this phenomenon was attributable to the substantial decrease in Akt phosphorylation induced by SPRY4 suppression, thereby impeding tumorigenesis <sup><a href="#CR52" class="usa-link" aria-describedby="CR52">52</a></sup>. The other inquiry, executed by Pan et al. on gastric cancer (GC) tumor tissue and non-tumor GC tissue specimens, highlighted that the expression of SPRY4 was markedly elevated in tumor tissues in comparison to non-tumor tissues. Furthermore, they demonstrated that diminished SPRY4 expression resulted in a significant reduction of proliferation and migratory capacity of GC cells. Their achievement depicted that the interaction of H3K4me2 with the oncogenic SPRY4 promoter region facilitated an increase in SPRY4 expression, thereby amplifying its oncogenic potential <sup><a href="#CR53" class="usa-link" aria-describedby="CR53">53</a></sup>. The findings from two previous studies exhibited the specific function of SPRY4, aligning with the results of our research. The observed discrepancies in SPRY4 expression may be attributed to some determinants: (1) cancer type specificity (e.g., the oncogenic function of SPRY4 in certain cell lines such as 833K and NT2-D1 cell lines, but a tumor-suppressive role in other cell lines); (2) molecular pathway, such as the involvement of the PI3K/AKT pathway, which could modulate functionality (for example, the phosphorylation of Akt by SPRY4 in TGCT); (3) epigenetic regulation (for instance, the oncogenic role of SPRY4 owing to the role of H3K4me2 in gastric carcinoma). Since in our study, we assessed the expression levels of the SPRY4 gene rather than the associated signaling pathways, elucidation of the precise mechanisms through which SPRY4 operates in CML necessitates further exploration. Nonetheless, in light of the two recent researches, the specific role of SPRY4 may be due to the variations in the phosphorylation status of Akt or the binding affinity of H3K4me2 to the SPRY4 promoter.</p>
<p id="Par17">
It should be highlighted that the necessity for a more extensive investigation to ascertain whether the variables delineated in this manuscript (sample size, heterogeneous clinicopathological characteristics of cancer patients, cancer type specificity, epigenetic regulation, and molecular pathway) are responsible for the observed discrepancies in the expression of the SPRY4 and miR-411 genes is paramount, as this would enable the examination of the influence of each factor and ultimately yield a conclusive determination. In the present study, owing to limitations in performing additional experiments, we hypothesize that these factors constitute significant contributors to the observed discrepancies in the expression profiles of these genes.</p>
<p id="Par18">
Considering the distinct expression patterns of miR-411 and SPRY4 across different phases of CML, future studies should focus on exploring their functional impact using experimental models. For instance, CML cell lines such as K562 or LAMA84 could be employed to perform gene modulation assays—either through overexpression or knockdown approaches (e.g., siRNA, miRNA mimics/inhibitors). Additionally, techniques such as luciferase reporter assays and Western blot analysis could be utilized to investigate downstream effects on signaling pathways potentially involving GRB2, β-catenin, or Akt. These approaches may help clarify the mechanistic roles of miR-411 and SPRY4 in CML pathogenesis.</p>
<p id="Par19">
To the best of our knowledge, this was the first study to measure the expression levels of two genes, SPRY4 and miR-411, in different phases of patients with CML, so it was not possible to compare with previous CML findings. However, our research was subjected to some limitations: 1. The number of included patients was relatively small, particularly the subset of patients in the blast crisis phase, which is due to the low probability of patients entering this phase; 2. Molecular subtype data (e.g., IKZF1) were not available; 3. Some patients exhibited reluctance to cooperate in providing biological sample; 4. Insufficient funding hampered our ability to conduct additional assessment aimed at delineating the precise functionalities of SPRY4 and miR-411 molecules; 5. Not conducting luciferase assay or Western blot for corroborating the involvement of SPRY4 and miR-411 genes in CML; 6. All patients in post-treatment phase were treated with imatinib; 7. Just 2,1, and 1 patients achieved MR4, MR4.5, and MR5 respectively, which are the optimal response after one year of treatment with TKIs.</p></section><section id="Sec13"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par20">
This investigation elucidates a phase-specific duality in the expression of SPRY4 and miR-411 in CML. Nevertheless, SPRY4 exhibits a downregulation subsequent to treatment yet an upregulation during blast crisis, indicating contextually dependent oncogenic functions, which may be potentially mediated by RAS/ERK feedback mechanisms or through epigenetic alterations (e.g., H3K4me2 promoter interaction). Conversely, miR-411 demonstrates an opposing trend, which correlates with tumor-suppressive activities, probably via the inhibition of GRB2 or the suppression of β-catenin, although its lineage-specific duality (oncogenic in solid tumors) necessitates careful consideration. In the end, on one hand, the expression patterns and roles of these two genes may vary across different malignancies, and on the other hand, the limited sample size in our study, as well as in most existing studies, underscores the issue that more extensive research with larger sample sizes should be conducted to elucidate the precise mechanisms by which these two molecules operate in various cancers, particularly in hematological malignancies such as CML.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>
The present paper is derived from an M.Sc. thesis supported by the Iran University of Medical Sciences. The authors greatly appreciate the deputy of Research &amp; Technology of Iran University of Medical Sciences for their assistance with this project.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>A.S. and N.A. performed the experiments, analyzed the data, and drafted the manuscript. A.A., B.CH., SH.R. and M.S. developed the study concept and design. A.S. and A.A. contributed to the data interpretation and critically revised the manuscript. A.A. and B.CH. conceived the study and interpreted the data. All authors approved the final version of the manuscript for submission.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The current work was funded by grant No. 26350 from Iran University of Medical Sciences. The authors have no relevant financial or non-financial interests to disclose.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par21">The authors declare no competing interests.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Ethical approval</h3>
<p id="Par22">This study was approved by the Medical Ethics Committee of Iran University of Medical Sciences (agreement number IR.IUMS.REC.1402.196).</p></section><section id="FPar3"><h3 class="pmc_sec_title">Informed consent</h3>
<p id="Par23">Written informed consent was obtained from all participants for publication of the details of their medical cases before the study.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Bahram Chahardouli, Email: bchahardouli@tums.ac.ir.</p>
<p>Ali Amini, Email: amini.a20@iums.ac.ir.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Jabbour, E. &amp; Kantarjian, H. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring. <em>Am. J. Hematol.</em><strong>99</strong>(11), 2191–2212. 10.1002/ajh.27443 (2024).
</cite> [<a href="https://doi.org/10.1002/ajh.27443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39093014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jabbour,%20E.%20&amp;%20Kantarjian,%20H.%20Chronic%20myeloid%20leukemia:%202025%20update%20on%20diagnosis,%20therapy,%20and%20monitoring.%20Am.%20J.%20Hematol.99(11),%202191%E2%80%932212.%2010.1002/ajh.27443%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Lin, Q. et al. Global, regional, and national burden of chronic myeloid leukemia, 1990–2017: A systematic analysis for the global burden of disease study 2017. <em>Front. Oncol.</em><strong>10</strong>, 580759. 10.3389/fonc.2020.580759 (2020).
</cite> [<a href="https://doi.org/10.3389/fonc.2020.580759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7770240/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33384954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin,%20Q.%20et%20al.%20Global,%20regional,%20and%20national%20burden%20of%20chronic%20myeloid%20leukemia,%201990%E2%80%932017:%20A%20systematic%20analysis%20for%20the%20global%20burden%20of%20disease%20study%202017.%20Front.%20Oncol.10,%20580759.%2010.3389/fonc.2020.580759%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Hoglund, M., Sandin, F. &amp; Simonsson, B. Epidemiology of chronic myeloid leukaemia: An update. <em>Ann. Hematol.</em><strong>94</strong>(Suppl 2), S241–S247. 10.1007/s00277-015-2314-2 (2015).
</cite> [<a href="https://doi.org/10.1007/s00277-015-2314-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25814090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hoglund,%20M.,%20Sandin,%20F.%20&amp;%20Simonsson,%20B.%20Epidemiology%20of%20chronic%20myeloid%20leukaemia:%20An%20update.%20Ann.%20Hematol.94(Suppl%202),%20S241%E2%80%93S247.%2010.1007/s00277-015-2314-2%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Chang, C.-S. et al. Estimation of CML incidence: Disagreement between national cancer registry and health claims data system in Taiwan. <em>Leuk. Res.</em><strong>35</strong>(5), e53–e54. 10.1016/j.canep.2022.102175 (2011).
</cite> [<a href="https://doi.org/10.1016/j.leukres.2010.12.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21255835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chang,%20C.-S.%20et%20al.%20Estimation%20of%20CML%20incidence:%20Disagreement%20between%20national%20cancer%20registry%20and%20health%20claims%20data%20system%20in%20Taiwan.%20Leuk.%20Res.35(5),%20e53%E2%80%93e54.%2010.1016/j.canep.2022.102175%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Chen, Y. et al. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. <em>Leuk Lymphoma</em><strong>54</strong>(7), 1411–1417. 10.3109/10428194.2012.745525 (2013).
</cite> [<a href="https://doi.org/10.3109/10428194.2012.745525" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5525971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23121646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20Y.%20et%20al.%20Trends%20in%20chronic%20myeloid%20leukemia%20incidence%20and%20survival%20in%20the%20United%20States%20from%201975%20to%202009.%20Leuk%20Lymphoma54(7),%201411%E2%80%931417.%2010.3109/10428194.2012.745525%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Al Hamad, M. Contribution of BCR-ABL molecular variants and leukemic stem cells in response and resistance to tyrosine kinase inhibitors: A review. <em>F1000Research</em><strong>10</strong>, 1288. 10.12688/f1000research.74570.2 (2022).</cite> [<a href="https://doi.org/10.12688/f1000research.74570.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8886173/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35284066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Al%20Hamad,%20M.%20Contribution%20of%20BCR-ABL%20molecular%20variants%20and%20leukemic%20stem%20cells%20in%20response%20and%20resistance%20to%20tyrosine%20kinase%20inhibitors:%20A%20review.%20F1000Research10,%201288.%2010.12688/f1000research.74570.2%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Samad, M. A., Mahboob, E. &amp; Mansoor, H. Chronic myeloid leukemia: a type of MPN. <em>Blood Res.</em><strong>57</strong>(2), 95–100. 10.5045/br.2022.2021173 (2022).
</cite> [<a href="https://doi.org/10.5045/br.2022.2021173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9242828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35620905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Samad,%20M.%20A.,%20Mahboob,%20E.%20&amp;%20Mansoor,%20H.%20Chronic%20myeloid%20leukemia:%20a%20type%20of%20MPN.%20Blood%20Res.57(2),%2095%E2%80%93100.%2010.5045/br.2022.2021173%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Suttorp, M. et al. Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia. <em>Cancers (Basel)</em><strong>13</strong>(4), 798. 10.3390/cancers13040798 (2021).
</cite> [<a href="https://doi.org/10.3390/cancers13040798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7917817/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33672937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suttorp,%20M.%20et%20al.%20Definition,%20epidemiology,%20pathophysiology,%20and%20essential%20criteria%20for%20diagnosis%20of%20pediatric%20chronic%20myeloid%20leukemia.%20Cancers%20(Basel)13(4),%20798.%2010.3390/cancers13040798%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Amini, A. et al. Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia. <em>Mol. Biol. Rep.</em><strong>41</strong>, 5557–5561. 10.1007/s11033-014-3472-3 (2014).
</cite> [<a href="https://doi.org/10.1007/s11033-014-3472-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25015264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Amini,%20A.%20et%20al.%20Expression%20pattern%20of%20hTERT%20telomerase%20subunit%20gene%20in%20different%20stages%20of%20chronic%20myeloid%20leukemia.%20Mol.%20Biol.%20Rep.41,%205557%E2%80%935561.%2010.1007/s11033-014-3472-3%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Rowley, J. D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. <em>Nature</em><strong>243</strong>(5405), 290–293. 10.1038/243290a0 (1973).
</cite> [<a href="https://doi.org/10.1038/243290a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4126434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rowley,%20J.%20D.%20Letter:%20A%20new%20consistent%20chromosomal%20abnormality%20in%20chronic%20myelogenous%20leukaemia%20identified%20by%20quinacrine%20fluorescence%20and%20Giemsa%20staining.%20Nature243(5405),%20290%E2%80%93293.%2010.1038/243290a0%20(1973)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Mandanas, R. A. et al. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells. <em>Blood</em><strong>82</strong>(6), 1838–1847. 10.1182/blood.V82.6.1838.1838 (1993).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7691239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mandanas,%20R.%20A.%20et%20al.%20Role%20of%20p21%20RAS%20in%20p210%20bcr-abl%20transformation%20of%20murine%20myeloid%20cells.%20Blood82(6),%201838%E2%80%931847.%2010.1182/blood.V82.6.1838.1838%20(1993)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Okuda, K. et al. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. <em>Exp. Hematol.</em><strong>22</strong>(11), 1111–1117 (1994).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7925778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Okuda,%20K.%20et%20al.%20Factor%20independence%20of%20human%20myeloid%20leukemia%20cell%20lines%20is%20associated%20with%20increased%20phosphorylation%20of%20the%20proto-oncogene%20Raf-1.%20Exp.%20Hematol.22(11),%201111%E2%80%931117%20(1994)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Raitano, A. B. et al. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. <em>Proc. Natl. Acad. Sci. USA</em><strong>92</strong>(25), 11746–11750. 10.1073/pnas.92.25.11746 (1995).
</cite> [<a href="https://doi.org/10.1073/pnas.92.25.11746" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC40479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8524841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raitano,%20A.%20B.%20et%20al.%20The%20Bcr-Abl%20leukemia%20oncogene%20activates%20Jun%20kinase%20and%20requires%20Jun%20for%20transformation.%20Proc.%20Natl.%20Acad.%20Sci.%20USA92(25),%2011746%E2%80%9311750.%2010.1073/pnas.92.25.11746%20(1995)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Sawyers, C. L., Callahan, W. &amp; Witte, O. N. Dominant negative MYC blocks transformation by ABL oncogenes. <em>Cell</em><strong>70</strong>(6), 901–910. 10.1016/0092-8674(92)90241-4 (1992).
</cite> [<a href="https://doi.org/10.1016/0092-8674(92)90241-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1525828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sawyers,%20C.%20L.,%20Callahan,%20W.%20&amp;%20Witte,%20O.%20N.%20Dominant%20negative%20MYC%20blocks%20transformation%20by%20ABL%20oncogenes.%20Cell70(6),%20901%E2%80%93910.%2010.1016/0092-8674(92)90241-4%20(1992)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Carlesso, N., Frank, D. A. &amp; Griffin, J. D. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. <em>J. Exp. Med.</em><strong>183</strong>(3), 811–820. 10.1084/jem.183.3.811 (1996).
</cite> [<a href="https://doi.org/10.1084/jem.183.3.811" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2192351/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8642285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carlesso,%20N.,%20Frank,%20D.%20A.%20&amp;%20Griffin,%20J.%20D.%20Tyrosyl%20phosphorylation%20and%20DNA%20binding%20activity%20of%20signal%20transducers%20and%20activators%20of%20transcription%20(STAT)%20proteins%20in%20hematopoietic%20cell%20lines%20transformed%20by%20Bcr/Abl.%20J.%20Exp.%20Med.183(3),%20811%E2%80%93820.%2010.1084/jem.183.3.811%20(1996)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Hacohen, N. et al. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. <em>Cell</em><strong>92</strong>(2), 253–263. 10.1016/S0092-8674(00)80919-8 (1998).
</cite> [<a href="https://doi.org/10.1016/s0092-8674(00)80919-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9458049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hacohen,%20N.%20et%20al.%20sprouty%20encodes%20a%20novel%20antagonist%20of%20FGF%20signaling%20that%20patterns%20apical%20branching%20of%20the%20Drosophila%20airways.%20Cell92(2),%20253%E2%80%93263.%2010.1016/S0092-8674(00)80919-8%20(1998)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Kramer, S. et al. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. <em>Development</em><strong>126</strong>(11), 2515–2525. 10.1242/dev.126.11.2515 (1999).
</cite> [<a href="https://doi.org/10.1242/dev.126.11.2515" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10226010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kramer,%20S.%20et%20al.%20Sprouty:%20A%20common%20antagonist%20of%20FGF%20and%20EGF%20signaling%20pathways%20in%20Drosophila.%20Development126(11),%202515%E2%80%932525.%2010.1242/dev.126.11.2515%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Leeksma, O. C. et al. Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1. <em>Eur. J. Biochem.</em><strong>269</strong>(10), 2546–2556. 10.1046/j.1432-1033.2002.02921.x (2002).
</cite> [<a href="https://doi.org/10.1046/j.1432-1033.2002.02921.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12027893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leeksma,%20O.%20C.%20et%20al.%20Human%20sprouty%204,%20a%20new%20ras%20antagonist%20on%205q31,%20interacts%20with%20the%20dual%20specificity%20kinase%20TESK1.%20Eur.%20J.%20Biochem.269(10),%202546%E2%80%932556.%2010.1046/j.1432-1033.2002.02921.x%20(2002)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Pan, H., Xu, R. &amp; Zhang, Y. Role of SPRY4 in health and disease. <em>Front. Oncol.</em><strong>14</strong>, 1376873. 10.3389/fonc.2024.1376873 (2024).
</cite> [<a href="https://doi.org/10.3389/fonc.2024.1376873" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11056578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38686189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pan,%20H.,%20Xu,%20R.%20&amp;%20Zhang,%20Y.%20Role%20of%20SPRY4%20in%20health%20and%20disease.%20Front.%20Oncol.14,%201376873.%2010.3389/fonc.2024.1376873%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Ding, W. et al. Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis. <em>Am. J. Physiol. Lung Cell Mol. Physiol.</em><strong>287</strong>(1), L52–L59. 10.1152/ajplung.00430.2003 (2004).
</cite> [<a href="https://doi.org/10.1152/ajplung.00430.2003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14977631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding,%20W.%20et%20al.%20Genomic%20structure%20and%20promoter%20characterization%20of%20the%20human%20Sprouty4%20gene,%20a%20novel%20regulator%20of%20lung%20morphogenesis.%20Am.%20J.%20Physiol.%20Lung%20Cell%20Mol.%20Physiol.287(1),%20L52%E2%80%93L59.%2010.1152/ajplung.00430.2003%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Masoumi-Moghaddam, S., Amini, A. &amp; Morris, D. L. The developing story of Sprouty and cancer. <em>Cancer Metastasis. Rev.</em><strong>33</strong>(2–3), 695–720. 10.1007/s10555-014-9497-1 (2014).
</cite> [<a href="https://doi.org/10.1007/s10555-014-9497-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4113681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24744103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Masoumi-Moghaddam,%20S.,%20Amini,%20A.%20&amp;%20Morris,%20D.%20L.%20The%20developing%20story%20of%20Sprouty%20and%20cancer.%20Cancer%20Metastasis.%20Rev.33(2%E2%80%933),%20695%E2%80%93720.%2010.1007/s10555-014-9497-1%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Mason, J. M. et al. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. <em>Trends Cell Biol.</em><strong>16</strong>(1), 45–54. 10.1016/j.tcb.2005.11.004 (2006).
</cite> [<a href="https://doi.org/10.1016/j.tcb.2005.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16337795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mason,%20J.%20M.%20et%20al.%20Sprouty%20proteins:%20multifaceted%20negative-feedback%20regulators%20of%20receptor%20tyrosine%20kinase%20signaling.%20Trends%20Cell%20Biol.16(1),%2045%E2%80%9354.%2010.1016/j.tcb.2005.11.004%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Taniguchi, K. et al. Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. <em>Biochem. Biophys. Res. Commun.</em><strong>352</strong>(4), 896–902. 10.1016/j.bbrc.2006.11.107 (2007).
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2006.11.107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17156747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Taniguchi,%20K.%20et%20al.%20Sprouty2%20and%20Sprouty4%20are%20essential%20for%20embryonic%20morphogenesis%20and%20regulation%20of%20FGF%20signaling.%20Biochem.%20Biophys.%20Res.%20Commun.352(4),%20896%E2%80%93902.%2010.1016/j.bbrc.2006.11.107%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Fukaya, T. et al. Loss of Sprouty4 in T cells ameliorates experimental autoimmune encephalomyelitis in mice by negatively regulating IL-1beta receptor expression. <em>Biochem. Biophys. Res. Commun.</em><strong>447</strong>(3), 471–478. 10.1016/j.bbrc.2014.04.012 (2014).
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2014.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24732356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fukaya,%20T.%20et%20al.%20Loss%20of%20Sprouty4%20in%20T%20cells%20ameliorates%20experimental%20autoimmune%20encephalomyelitis%20in%20mice%20by%20negatively%20regulating%20IL-1beta%20receptor%20expression.%20Biochem.%20Biophys.%20Res.%20Commun.447(3),%20471%E2%80%93478.%2010.1016/j.bbrc.2014.04.012%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Klimaschewski, L., Sueiro, B. P. &amp; Millan, L. M. siRNA mediated down-regulation of Sprouty2/4 diminishes ischemic brain injury. <em>Neurosci. Lett.</em><strong>612</strong>, 48–51. 10.1016/j.neulet.2015.11.050 (2016).
</cite> [<a href="https://doi.org/10.1016/j.neulet.2015.11.050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26655476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klimaschewski,%20L.,%20Sueiro,%20B.%20P.%20&amp;%20Millan,%20L.%20M.%20siRNA%20mediated%20down-regulation%20of%20Sprouty2/4%20diminishes%20ischemic%20brain%20injury.%20Neurosci.%20Lett.612,%2048%E2%80%9351.%2010.1016/j.neulet.2015.11.050%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Guo, J. et al. SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2. <em>Aging (Albany NY)</em><strong>13</strong>(8), 11665–11677. 10.18632/aging.202859 (2021).
</cite> [<a href="https://doi.org/10.18632/aging.202859" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8109073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33879635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo,%20J.%20et%20al.%20SPRY4%20suppresses%20proliferation%20and%20induces%20apoptosis%20of%20colorectal%20cancer%20cells%20by%20repressing%20oncogene%20EZH2.%20Aging%20(Albany%20NY)13(8),%2011665%E2%80%9311677.%2010.18632/aging.202859%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Qin, S. et al. SPRY4 regulates trophoblast proliferation and apoptosis via regulating IFN-gamma-induced STAT1 expression and activation in recurrent miscarriage. <em>Am. J. Reprod. Immunol.</em><strong>83</strong>(6), e13234. 10.1111/aji.13234 (2020).
</cite> [<a href="https://doi.org/10.1111/aji.13234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32196809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin,%20S.%20et%20al.%20SPRY4%20regulates%20trophoblast%20proliferation%20and%20apoptosis%20via%20regulating%20IFN-gamma-induced%20STAT1%20expression%20and%20activation%20in%20recurrent%20miscarriage.%20Am.%20J.%20Reprod.%20Immunol.83(6),%20e13234.%2010.1111/aji.13234%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Goldshmit, Y. et al. Decreased anti-regenerative effects after spinal cord injury in spry4-/- mice. <em>Neuroscience</em><strong>287</strong>, 104–112. 10.1016/j.neuroscience.2014.12.020 (2015).
</cite> [<a href="https://doi.org/10.1016/j.neuroscience.2014.12.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25541251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goldshmit,%20Y.%20et%20al.%20Decreased%20anti-regenerative%20effects%20after%20spinal%20cord%20injury%20in%20spry4-/-%20mice.%20Neuroscience287,%20104%E2%80%93112.%2010.1016/j.neuroscience.2014.12.020%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Taniguchi, K. et al. Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. <em>PLoS ONE</em><strong>4</strong>(5), e5467. 10.1371/journal.pone.0005467 (2009).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0005467" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2674940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19424491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Taniguchi,%20K.%20et%20al.%20Suppression%20of%20Sproutys%20has%20a%20therapeutic%20effect%20for%20a%20mouse%20model%20of%20ischemia%20by%20enhancing%20angiogenesis.%20PLoS%20ONE4(5),%20e5467.%2010.1371/journal.pone.0005467%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Niu, Z. S. et al. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. <em>World J. Gastroenterol.</em><strong>26</strong>(29), 4240–4260. 10.3748/wjg.v26.i29.4240 (2020).
</cite> [<a href="https://doi.org/10.3748/wjg.v26.i29.4240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7422540/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32848331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Niu,%20Z.%20S.%20et%20al.%20Role%20of%20long%20noncoding%20RNA-mediated%20competing%20endogenous%20RNA%20regulatory%20network%20in%20hepatocellular%20carcinoma.%20World%20J.%20Gastroenterol.26(29),%204240%E2%80%934260.%2010.3748/wjg.v26.i29.4240%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Wright, M. W. &amp; Bruford, E. A. Naming’junk’: Human non-protein coding RNA (ncRNA) gene nomenclature. <em>Hum. Genom.</em><strong>5</strong>, 1–9. 10.1186/1479-7364-5-2-90 (2011).</cite> [<a href="https://doi.org/10.1186/1479-7364-5-2-90" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3051107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21296742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wright,%20M.%20W.%20&amp;%20Bruford,%20E.%20A.%20Naming%E2%80%99junk%E2%80%99:%20Human%20non-protein%20coding%20RNA%20(ncRNA)%20gene%20nomenclature.%20Hum.%20Genom.5,%201%E2%80%939.%2010.1186/1479-7364-5-2-90%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Zhang, C. et al. Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP. <em>Oncogene</em><strong>38</strong>(11), 1892–1904. 10.1038/s41388-018-0534-3 (2019).
</cite> [<a href="https://doi.org/10.1038/s41388-018-0534-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6475890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30390072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20C.%20et%20al.%20Oncogenic%20microRNA-411%20promotes%20lung%20carcinogenesis%20by%20directly%20targeting%20suppressor%20genes%20SPRY4%20and%20TXNIP.%20Oncogene38(11),%201892%E2%80%931904.%2010.1038/s41388-018-0534-3%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Zou, M. et al. Dysregulation of miR-411 in cancer: Causative factor for pathogenesis, diagnosis and prognosis. <em>Biomed. Pharmacother</em><strong>149</strong>, 112896. 10.1016/j.biopha.2022.112896 (2022).
</cite> [<a href="https://doi.org/10.1016/j.biopha.2022.112896" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35358797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zou,%20M.%20et%20al.%20Dysregulation%20of%20miR-411%20in%20cancer:%20Causative%20factor%20for%20pathogenesis,%20diagnosis%20and%20prognosis.%20Biomed.%20Pharmacother149,%20112896.%2010.1016/j.biopha.2022.112896%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Kozomara, A., Birgaoanu, M. &amp; Griffiths-Jones, S. miRBase: from microRNA sequences to function. <em>Nucleic Acids Res.</em><strong>47</strong>(D1), D155–D162. 10.1093/nar/gky1141 (2019).
</cite> [<a href="https://doi.org/10.1093/nar/gky1141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6323917/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30423142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kozomara,%20A.,%20Birgaoanu,%20M.%20&amp;%20Griffiths-Jones,%20S.%20miRBase:%20from%20microRNA%20sequences%20to%20function.%20Nucleic%20Acids%20Res.47(D1),%20D155%E2%80%93D162.%2010.1093/nar/gky1141%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Liu, R. et al. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/beta-catenin pathway. <em>World J. Surg. Oncol.</em><strong>19</strong>(1), 51. 10.1186/s12957-021-02164-y (2021).
</cite> [<a href="https://doi.org/10.1186/s12957-021-02164-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7891146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33596920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20R.%20et%20al.%20Circ_0082182%20promotes%20oncogenesis%20and%20metastasis%20of%20colorectal%20cancer%20in%20vitro%20and%20in%20vivo%20by%20sponging%20miR-411%20and%20miR-1205%20to%20activate%20the%20Wnt/beta-catenin%20pathway.%20World%20J.%20Surg.%20Oncol.19(1),%2051.%2010.1186/s12957-021-02164-y%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>He, F. et al. hsa-microRNA-411-5p regulates proliferation, migration and invasion by targeting the hyaluronan mediated motility receptor in ovarian cancer. <em>Exp. Ther. Med.</em><strong>20</strong>(3), 1899–1906. 10.3892/etm.2020.8899 (2020).
</cite> [<a href="https://doi.org/10.3892/etm.2020.8899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7401286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32782498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He,%20F.%20et%20al.%20hsa-microRNA-411-5p%20regulates%20proliferation,%20migration%20and%20invasion%20by%20targeting%20the%20hyaluronan%20mediated%20motility%20receptor%20in%20ovarian%20cancer.%20Exp.%20Ther.%20Med.20(3),%201899%E2%80%931906.%2010.3892/etm.2020.8899%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Wei, W. &amp; Liu, C. Prognostic and predictive roles of microRNA-411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer. <em>Mol. Med. Rep.</em><strong>21</strong>(1), 267–281. 10.3892/mmr.2019.10826 (2020).
</cite> [<a href="https://doi.org/10.3892/mmr.2019.10826" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6896360/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31746360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei,%20W.%20&amp;%20Liu,%20C.%20Prognostic%20and%20predictive%20roles%20of%20microRNA-411%20and%20its%20target%20STK17A%20in%20evaluating%20radiotherapy%20efficacy%20and%20their%20effects%20on%20cell%20migration%20and%20invasion%20via%20the%20p53%20signaling%20pathway%20in%20cervical%20cancer.%20Mol.%20Med.%20Rep.21(1),%20267%E2%80%93281.%2010.3892/mmr.2019.10826%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Zhang, Y. et al. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. <em>Biochem. Biophys. Res. Commun.</em><strong>476</strong>(4), 607–613. 10.1016/j.bbrc.2016.06.006 (2016).
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2016.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27264952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20Y.%20et%20al.%20miR-411-5p%20inhibits%20proliferation%20and%20metastasis%20of%20breast%20cancer%20cell%20via%20targeting%20GRB2.%20Biochem.%20Biophys.%20Res.%20Commun.476(4),%20607%E2%80%93613.%2010.1016/j.bbrc.2016.06.006%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Sun, M. et al. Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation. <em>Cell Death Dis.</em><strong>6</strong>(8), e1859–e1859. 10.1038/cddis.2015.225 (2015).
</cite> [<a href="https://doi.org/10.1038/cddis.2015.225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4558514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26291313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun,%20M.%20et%20al.%20Autoregulatory%20loop%20between%20TGF-%CE%B21/miR-411-5p/SPRY4%20and%20MAPK%20pathway%20in%20rhabdomyosarcoma%20modulates%20proliferation%20and%20differentiation.%20Cell%20Death%20Dis.6(8),%20e1859%E2%80%93e1859.%2010.1038/cddis.2015.225%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Pan, H. &amp; Zhang, Y. Role of SPRY4 in health and disease. <em>Front. Oncol.</em><strong>14</strong>, 1376873. 10.3389/fonc.2024.1376873 (2024).
</cite> [<a href="https://doi.org/10.3389/fonc.2024.1376873" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11056578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38686189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pan,%20H.%20&amp;%20Zhang,%20Y.%20Role%20of%20SPRY4%20in%20health%20and%20disease.%20Front.%20Oncol.14,%201376873.%2010.3389/fonc.2024.1376873%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Romano, G. et al. A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells. <em>Oncogene</em><strong>42</strong>(19), 1597–1606. 10.1038/s41388-023-02673-y (2023).
</cite> [<a href="https://doi.org/10.1038/s41388-023-02673-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10336698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37002315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Romano,%20G.%20et%20al.%20A-to-I%20edited%20miR-411-5p%20targets%20MET%20and%20promotes%20TKI%20response%20in%20NSCLC-resistant%20cells.%20Oncogene42(19),%201597%E2%80%931606.%2010.1038/s41388-023-02673-y%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Amarante-Mendes, G. P. et al. BCR-ABL1 tyrosine kinase complex signaling transduction: Challenges to overcome resistance in chronic myeloid leukemia. <em>Pharmaceutics</em><strong>14</strong>(1), 215. 10.3390/pharmaceutics14010215 (2022).
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14010215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8780254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35057108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Amarante-Mendes,%20G.%20P.%20et%20al.%20BCR-ABL1%20tyrosine%20kinase%20complex%20signaling%20transduction:%20Challenges%20to%20overcome%20resistance%20in%20chronic%20myeloid%20leukemia.%20Pharmaceutics14(1),%20215.%2010.3390/pharmaceutics14010215%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Quintas-Cardama, A. &amp; Cortes, J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. <em>Blood</em><strong>113</strong>(8), 1619–1630. 10.1182/blood-2008-03-144790 (2009).
</cite> [<a href="https://doi.org/10.1182/blood-2008-03-144790" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3952549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18827185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Quintas-Cardama,%20A.%20&amp;%20Cortes,%20J.%20Molecular%20biology%20of%20bcr-abl1-positive%20chronic%20myeloid%20leukemia.%20Blood113(8),%201619%E2%80%931630.%2010.1182/blood-2008-03-144790%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Tari, A. M. &amp; Lopez-Berestein, G. GRB2: A pivotal protein in signal transduction. In <em>Seminars in oncology</em>. (Elsevier, 2001). 10.1016/S0093-7754(01)90291-X</cite> [<a href="https://doi.org/10.1016/s0093-7754(01)90291-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11706405/" class="usa-link">PubMed</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Xia, K. et al. miR-411 regulated ITCH expression and promoted cell proliferation in human hepatocellular carcinoma cells. <em>Biomed. Pharmacother.</em><strong>70</strong>, 158–163. 10.1016/j.biopha.2015.01.001 (2015).
</cite> [<a href="https://doi.org/10.1016/j.biopha.2015.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25776495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia,%20K.%20et%20al.%20miR-411%20regulated%20ITCH%20expression%20and%20promoted%20cell%20proliferation%20in%20human%20hepatocellular%20carcinoma%20cells.%20Biomed.%20Pharmacother.70,%20158%E2%80%93163.%2010.1016/j.biopha.2015.01.001%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Zhao, W. X. et al. Up-regulation of circ_0000353 impedes the proliferation and metastasis of non-small cell lung cancer cells via adsorbing miR-411-5p and increasing forkhead box O1. <em>Cancer Biomark</em><strong>29</strong>(1), 25–37. 10.3233/CBM-190812 (2020).
</cite> [<a href="https://doi.org/10.3233/CBM-190812" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32568175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao,%20W.%20X.%20et%20al.%20Up-regulation%20of%20circ_0000353%20impedes%20the%20proliferation%20and%20metastasis%20of%20non-small%20cell%20lung%20cancer%20cells%20via%20adsorbing%20miR-411-5p%20and%20increasing%20forkhead%20box%20O1.%20Cancer%20Biomark29(1),%2025%E2%80%9337.%2010.3233/CBM-190812%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Xu, N. et al. MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression. <em>Environ. Sci. Pollut. Res. Int.</em><strong>25</strong>(12), 12064–12071. 10.1007/s11356-018-1331-9 (2018).
</cite> [<a href="https://doi.org/10.1007/s11356-018-1331-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29453719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu,%20N.%20et%20al.%20MicroRNA-411%20promoted%20the%20osteosarcoma%20progression%20by%20suppressing%20MTSS1%20expression.%20Environ.%20Sci.%20Pollut.%20Res.%20Int.25(12),%2012064%E2%80%9312071.%2010.1007/s11356-018-1331-9%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Casci, T., Vinos, J. &amp; Freeman, M. Sprouty, an intracellular inhibitor of Ras signaling. <em>Cell</em><strong>96</strong>(5), 655–665. 10.1016/S0092-8674(00)80576-0 (1999).
</cite> [<a href="https://doi.org/10.1016/s0092-8674(00)80576-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10089881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Casci,%20T.,%20Vinos,%20J.%20&amp;%20Freeman,%20M.%20Sprouty,%20an%20intracellular%20inhibitor%20of%20Ras%20signaling.%20Cell96(5),%20655%E2%80%93665.%2010.1016/S0092-8674(00)80576-0%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Qiu, B. et al. Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle. <em>EBioMedicine</em><strong>50</strong>, 166–177. 10.1016/j.ebiom.2019.11.021 (2019).
</cite> [<a href="https://doi.org/10.1016/j.ebiom.2019.11.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6921364/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31761616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu,%20B.%20et%20al.%20Sprouty4%20correlates%20with%20favorable%20prognosis%20in%20perihilar%20cholangiocarcinoma%20by%20blocking%20the%20FGFR-ERK%20signaling%20pathway%20and%20arresting%20the%20cell%20cycle.%20EBioMedicine50,%20166%E2%80%93177.%2010.1016/j.ebiom.2019.11.021%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Zhou, X. et al. Lower expression of SPRY4 predicts a poor prognosis and regulates cell proliferation in colorectal cancer. <em>Cell Physiol. Biochem.</em><strong>40</strong>(6), 1433–1442. 10.1159/000453195 (2016).
</cite> [<a href="https://doi.org/10.1159/000453195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27997895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou,%20X.%20et%20al.%20Lower%20expression%20of%20SPRY4%20predicts%20a%20poor%20prognosis%20and%20regulates%20cell%20proliferation%20in%20colorectal%20cancer.%20Cell%20Physiol.%20Biochem.40(6),%201433%E2%80%931442.%2010.1159/000453195%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Geiger, O. et al. Deletion of SPRY4 is a frequent event in secondary acute myeloid leukemia. <em>Ann. Hematol.</em><strong>94</strong>, 1923–1924. 10.1007/s00277-015-2445-5 (2015).
</cite> [<a href="https://doi.org/10.1007/s00277-015-2445-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5024751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26204823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geiger,%20O.%20et%20al.%20Deletion%20of%20SPRY4%20is%20a%20frequent%20event%20in%20secondary%20acute%20myeloid%20leukemia.%20Ann.%20Hematol.94,%201923%E2%80%931924.%2010.1007/s00277-015-2445-5%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Das, M. K. et al. Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours. <em>Sci. Rep.</em><strong>8</strong>(1), 2462. 10.1038/s41598-018-20846-8 (2018).
</cite> [<a href="https://doi.org/10.1038/s41598-018-20846-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5802735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29410498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Das,%20M.%20K.%20et%20al.%20Knockdown%20of%20SPRY4%20and%20SPRY4-IT1%20inhibits%20cell%20growth%20and%20phosphorylation%20of%20Akt%20in%20human%20testicular%20germ%20cell%20tumours.%20Sci.%20Rep.8(1),%202462.%2010.1038/s41598-018-20846-8%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Pan, Y. et al. LINC00675 suppresses cell proliferation and migration via downregulating the H3K4me2 level at the SPRY4 promoter in gastric cancer. <em>Molecular Therapy-Nucleic Acids</em><strong>22</strong>, 766–778. 10.1016/j.omtn.2020.09.038 (2020).
</cite> [<a href="https://doi.org/10.1016/j.omtn.2020.09.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7595884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33230474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pan,%20Y.%20et%20al.%20LINC00675%20suppresses%20cell%20proliferation%20and%20migration%20via%20downregulating%20the%20H3K4me2%20level%20at%20the%20SPRY4%20promoter%20in%20gastric%20cancer.%20Molecular%20Therapy-Nucleic%20Acids22,%20766%E2%80%93778.%2010.1016/j.omtn.2020.09.038%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-13100-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_13100.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12368223/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12368223/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368223%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368223/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12368223/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12368223/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40835851/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12368223/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40835851/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12368223/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12368223/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6W0n9TeHKkYZlLGklJcmMIXUKXzbRm8jOV6Jtv8fDofUqu8fArIPH90xbHZrg8Ub">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
